Navigation Links
ATS Medical Announces First 'Frontiers in Cryoablation' Symposium
Date:4/30/2008

Event is Co-Sponsored by Intuitive Surgical and ATS Medical

MINNEAPOLIS, April 30 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first Frontiers in Cryoablation Symposium to be held at the American Association for Thoracic Surgery Annual Meeting in San Diego. The symposium is the first in a series of meetings intended to further the evolution and direction for cryoablation therapy, a treatment for atrial fibrillation. Dr. James L. Cox, inventor of the Maze procedure and Medical Director for ATS Medical, will lead the symposia series. The program will include a preeminent faculty of cardiac surgeons reporting on current techniques, robotics, and the future of minimally invasive cryoablation utilizing the ATS CryoMaze(TM) Surgical Ablation System.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

This first symposium, titled "Current Techniques, Robotics and the Future of Minimally Invasive Cryoablation" is sponsored collaboratively by ATS Medical and Intuitive Surgical, the makers of the da Vinci(R) Surgical System (Nasdaq: ISRG). The symposium follows the recent market release of Intuitive Surgical's Endowrist Cardiac Probe Grasper -- a device specifically designed to assist the da Vinci System in manipulating ATS CryoMaze Surgical Ablation Probes to complete the Cox Maze III procedure. The Symposium will be conducted on Sunday, May 11 at 7:00 pm.

"The Frontiers in Cryoablation Series will provide a forum for presenting the current capabilities of surgical cryoablation and allow physicians to collaborate on the future of minimally invasive techniques for the treatment of atrial fibrillation. I am excited about the opportunity to expand the application of cryoablation using minimal access and stand-alone procedures to maximize the benefit for surgeons and their patients," stated Dr. James Cox, Medical Director for ATS Medical.

The treatment of atrial fibrillation (AF) is believed to be the largest untapped opportunity in medical devices with an estimated multi-billion dollar market potential. In contrast, the current surgical market size is estimated at $121 million in 2007. Based on initial clinical results, management believes that only ATS has the technology -- the ATS CryoMaze Surgical Ablation System -- proven to yield clinical results similar to the conventional cut-and-sew Cox Maze III procedure, but with an approach involving small incisions. As such, the surgical AF business is expected to be a key growth opportunity for ATS in 2008 and beyond.

About ATS Medical

ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The Company, global in scope, is headquartered in Minneapolis, Minnesota. More than 145,000 ATS Open Pivot(R) Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3f(R) brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical's focus on serving the cardiac surgery community is further strengthened by offerings that include ATS Simulus(R) annuloplasty products for heart valve repair and ATS CryoMaze(TM) surgical ablation products. The ATS Medical web site is http://www.atsmedical.com.

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. (Nasdaq: ISRG), headquartered in Sunnyvale, California, is the global technology leader in the field of robotic-assisted, minimally invasive surgery (MIS). Intuitive Surgical develops, manufactures and markets robotic technologies designed to improve clinical outcomes and help patients return more quickly to active and productive lives. The company's mission is to extend the benefits of minimally invasive surgery to the broadest possible base of patients. More information is available at http://www.intuitivesurgical.com and http://www.davincisurgery.com. Intuitive Surgical -- Taking surgical precision beyond the limits of the human hand. (TM)

Safe Harbor

This Press Release contains forward-looking statements that may include statements regarding intent, belief or current expectations of the Company and its management. Actual results could differ materially from those projected in the forward looking statements as a result of a number of important factors, including the results of clinical trials, the timing of regulatory approvals, the integration of 3f Therapeutics and the surgical cryoablation business of CryoCath Technologies, Inc., regulatory actions, competition, pricing pressures, supplier actions and management of growth. For a discussion of these and other risks and uncertainties that could affect the Company's activities and results, please refer to the Company's filings with the Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2007.


'/>"/>
SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medical journal calls upon Barack Obama to do much more
2. ACP hosts largest medical education meeting for general and subspecialty internists
3. Flashpoint Medica Named Agency of Year by Medical Advertising News
4. Virginia Judge Rules Medical Device Pioneer Committed Malpractice
5. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
6. PSI Corp. Announces Additional Hospitals and Medical Office Buildings to Utilize Its Digital Signage Network
7. Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer
8. J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
9. Story of Womans Courage and Medical Innovation Top Choice for Readers
10. Houston Northwest Medical Center Caregiver Honored by Tenet Healthcare
11. Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... It has just been ... keynote speaker for five events throughout the month of May. , Uldrich is the ... national news outlets. He also frequently appears on the Science Channel’s FutureScape and Discovery ...
(Date:5/2/2016)... ... May 02, 2016 , ... As directed by its board of directors during ... full support to allow certified nurse practitioners (CNP) to practice to the full scope ... such supervision for three years and 3,600 hours. , In addition, HAP supports CNPs ...
(Date:5/2/2016)... ... May 02, 2016 , ... Eating Recovery Center’s Insight ... mood and anxiety disorders, has rebranded its eating disorder program under a new name: ... disorder treatment facility on May 16. , To celebrate, ERC Chicago will host ...
(Date:5/2/2016)... ... May 02, 2016 , ... The ... the 2016 Main Residency Match® (“the Match”), the system through which U.S. and ... institutions. A record-high 30,750 positions were placed in the 2016 Match, and 29,572 ...
(Date:5/2/2016)... CA (PRWEB) , ... May 02, 2016 , ... East ... on dental extractions. Currently, patients can visit Dr. Assili to receive any dental extraction ... other offer, and it expires June 30, 2016. With the lower price, patients can ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
(Date:4/27/2016)... --   , Total Sales ... Sales  Clinical sales grow 16% year-over-year  , ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... quarter ended March 31, 2016 and provided an update ... strategy. First Quarter 2016 Revenue Results by ...
Breaking Medicine Technology: